Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers
Latest Information Update: 28 Feb 2020
At a glance
- Drugs Cholesteryl palmitate/colfosceril palmitate (Primary)
- Indications Otitis media
- Focus Adverse reactions; First in man
- Sponsors Novus Therapeutics
- 10 Jun 2019 According to a Novus Therapeutics media release, data from this trial will be presented at the upcoming 20th International Symposium on Recent Advances in Otitis Media, being held June 9-13, 2019 in Los Angeles, CA.
- 14 May 2019 According to a Novus Therapeutics media release, data from this study is expected in June 2019.
- 22 Apr 2019 According to a Novus Therapeutics media release, the company expects to report data from the 14-day, dose-escalation safety and tolerability data in the coming months.